Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy in Diagnosing Breast Cancer

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Abstract of Fine Needle Aspiration

Received: July 04, 2022
Accepted: September 14, 2022
Published online: November 22, 2022

Number of Print Pages: 16
Number of Figures: 5
Number of Tables: 4

ISSN: 0001-5547 (Print)
eISSN: 1938-2650 (Online)

For additional information: https://www.karger.com/ACY

Abstract

Objectives: The primary objective is to determine the accuracy of fine-needle aspiration biopsy (FNAB) in breast lesions reported according to the International Academy of Cytology (IAC) Yokohama system for reporting breast FNAB. The participants include any patient presenting with any breast lesion found suitable for FNAB. The target condition was breast cancer. The secondary objective was to study the proportion of inadequate FNAB in the selected studies. Methods: PubMed/MEDLINE and Embase were searched for studies having all the following key search terms: Breast AND FNAB AND Diagnostic Accuracy published in the time frame of 2017 to May 16, 2022. The Cochrane and PROSPERO databases, citations of selected articles and articles citing the selected articles were also searched. Studies assessing the diagnostic accuracy of breast FNAB in diagnosing breast cancer, which had at least 75 subjects (and at least 20 subjects each in the benign and malignant FNAB groups), were selected. The reference standard was histopathology (or adequate clinical follow-up for benign disease). Studies were screened independently by two researchers, with a consensus reached among the authors in cases of conflict. The risk of bias and applicability were assessed using the QUADAS-2 tool. Sensitivity and specificity at each diagnostic cut-off were assessed by bivariate generalized linear mixed-model meta-analysis. The area under the receiver operating characteristics curve (AUC) and inadequacy rate were assessed by random-effects meta-analysis. The confidence intervals of sensitivity, specificity, and AUC were examined against a value of 0.95. Results: Twenty-two studies, all of which were cross-sectional single-gate studies, were selected with a total of 10,886 subjects with a primary breast lesion having concurrent FNAB and reference standard reports. Sensitivity and specificity, with 95% confidence intervals, were 0.978 [0.968, 0.985] and 0.832 [0.76, 0.886] for the diagnostic cut-off of “Atypical considered positive for malignancy,” 0.916 [0.892, 0.935] and 0.983 [0.97, 0.99] for the cut-off of “Suspicious of Malignancy considered positive,” and 0.763 [0.706, 0.812] and 0.999 [0.994, 1] for the cut-off of “Malignant considered positive.” The overall AUC was 0.975 [0.962, 0.984]. FNAB sampling without imaging guidance was associated with lower inadequacy. Discussion: There is strong evidence that the overall accuracy, sensitivity for “Atypical category considered positive” and specificity when “Suspicious or Malignant categories are considered positive” of FNAB are high when using the categories of the IAC Yokohama Reporting System, demonstrating the usefulness of FNAB in diagnosing breast cancer.

© 2022 S. Karger AG, Basel

References Field AS, Raymond WA, Schmitt F, editors. The International Academy of Cytology Yokohama System for reporting breast fine needle aspiration biopsy cytopathology. Cham, Switzerland: Springer International Publishing; 2020. Montezuma D, Malheiros D, Schmitt FC. Breast fine needle aspiration biopsy cytology using the newly proposed IAC Yokohama System for reporting breast cytopathology: the experience of a single institution. Acta Cytol. 2019 Feb;63(Suppl 4):274–9. Chauhan V, Pujani M, Agarwal C, Chandoke RK, Raychaudhuri S, Singh K, et al. IAC standardized reporting of breast fine-needle aspiration cytology, Yokohama 2016: a critical appraisal over a 2 year period. Breast Dis. 2019;38(3–4):109–15. Agarwal A, Singh D, Mehan A, Paul P, Puri N, Gupta P, et al. Accuracy of the International Academy of Cytology Yokohama System of breast cytology reporting for fine needle aspiration biopsy of the breast in a dedicated breast care setting. Diagn Cytopathol. 2021 Oct;49(2):195–202. McHugh KE, Bird P, Sturgis CD. Concordance of breast fine needle aspiration cytology interpretation with subsequent surgical pathology: An 18-year review from a single sub-Saharan African institution. Cytopathology. 2019 Sep;30(5):519–25. De Rosa F, Migliatico I, Vigliar E, Salatiello M, Pisapia P, Iaccarino A, et al. The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System for reporting breast fine needle aspiration biopsy cytopathology. Diagn Cytopathol. 2020 Aug;48(12):1244–53. Wong S, Rickard M, Earls P, Arnold L, Bako B, Field AS. The International Academy of Cytology Yokohama System for reporting breast fine needle aspiration biopsy cytopathology: a single institutional retrospective study of the application of the system categories and the impact of rapid onsite evaluation. Acta Cytol. 2019 Jun;63(4):280–91. Agrawal S, Anthony ML, Paul P, Singh D, Mehan A, Singh A, et al. Prospective evaluation of accuracy of fine-needle aspiration biopsy for breast lesions using the International Academy of Cytology Yokohama System for reporting breast cytopathology. Diagn Cytopathol. 2021;49(7):805–10. Dixit N, Trivedi S, Bansal VK. A retrospective analysis of 512 cases of breast fine needle aspiration cytology utilizing the recently proposed IAC Yokohama system for reporting breast cytopathology. Diagn Cytopathol. 2021;49(9):1022–31. Marabi M, Aphivatanasiri C, Jamidi SK, Wang C, Li JJ, Hung EH, et al. The International Academy of Cytology Yokohama System for reporting breast cytopathology showed improved diagnostic accuracy. Cancer Cytopathol. 2021 Nov;129(11):852–64. Wong YP, Vincent James EP, Mohammad Azhar MAA, Krishnamoorthy Y, Zainudin NA, Zamara F, et al. Implementation of the International Academy of Cytology Yokohama standardized reporting for breast cytopathology: an 8-year retrospective study. Diagn Cytopathol. 2021;49(6):718–26. Tejeswini V, Chaitra B, Renuka I, Laxmi K, Ramya P, Sowjanya K. Effectuation of international academy of cytology yokahama reporting system of breast cytology to assess malignancy risk and accuracy. J Cytol. 2021;38(2):69–73. Sundar PM, Shanmugasundaram S, Nagappan E. The role of the IAC Yokohama System for reporting breast fine needle aspiration biopsy and the ACR breast imaging-reporting and data system in the evaluation of breast lesions. Cytopathology. 2022 Mar;33(2):185–95. Nigam JS, Kumar T, Bharti S, Surabhi SR, Bhadani PP, et al. The International Academy of Cytology standardized reporting of breast fine-needle aspiration biopsy cytology: a 2 year’s retrospective study with application of categories and their assessment for risk of malignancy. Cytojournal. 2021 Nov;18:27. Agrawal N, Kothari K, Tummidi S, Sood P, Agnihotri M, Shah V. Fine-needle aspiration biopsy cytopathology of breast lesions using the International Academy of Cytology Yokohama System and rapid on-site evaluation: a single-institute experience. Acta Cytol. 2021;65(6):463–77. Sarangi S, Rao M, Elhence PA, Nalwa A, Bharti JN, Khera S, et al. Risk stratification of breast fine-needle aspiration biopsy specimens performed without radiologic guidance by application of the International Academy of Cytology Yokohama System for reporting breast fine-needle aspiration cytopathology. Acta Cytol. 2021 Nov;65(6):483–93. Nargund A, Mohan R, Pai MM, Sadasivan B, Dharmalingam P, Chennagiri P, et al. Demystifying breast fnac’s based on the international academy of cytology, yokohama breast cytopathology system- a retrospective study. J Clin Diagnostic Res. 2021;15(3):EC01–5. Ahuja S, Malviya A. Categorization of breast fine needle aspirates using the International Academy of Cytology Yokohama System along with assessment of risk of malignancy and diagnostic accuracy in a Tertiary Care Centre. J Cytol. 2021 Jul;38(3):158–63. Kamatar PV, Athanikar VS, Dinesh U. Breast fine needle aspiration biopsy cytology reporting using International Academy of Cytology Yokohama System-two year Retrospective Study in Tertiary Care Centre in Southern India. Natl J Lab Med. 2019;8(4):PO01–3. Apuroopa M, Chakravarthy VK, Rao DR. Application of yokohama system for reporting breast fine needle aspiration cytology in correlation with histopathological and radiological findings. Ann Pathol Lab Med. 2020 May;7(4):A210–215. Niaz M, Khan AA, Ahmed S, Rafi R, Salim H, Khalid K, et al. Risk of malignancy in breast FNAB categories, classified according to the newly proposed International Academy of Cytology (IAC) Yokohama System. Cancer Manag Res. 2022 May;14:1693. Deshpande S, Rao K, Sushma Y, Saikumar G. International academy of cytology guidelines based categorization of breast fine-needle aspiration cytology lesions and their histopathological correlation. J Datta Meghe Inst Med Sci Univ. 2021 Apr;16(2):334. Joshee A, Joshee R. Breast FNA cytology reporting using new proposed IAC Yokohama reporting system: a single institution retrospective study. Int J Adv Res Med. 2021;3(2):267–71. Agrawal S, Anthony ML, Paul P, Singh D, Agarwal A, Mehan A, et al. Accuracy of breast fine-needle aspiration biopsy using the International Academy of Cytology Yokohama System in clinico-radiologically indeterminate lesions: initial findings demonstrating value in lesions of low suspicion of malignancy. Acta Cytol. 2021;65(3):1–7. Field AS, Raymond WA, Schmitt F. The International Academy of Cytology Yokohama System for reporting breast fine-needle aspiration biopsy cytopathology: recent research findings and the future. Cancer Cytopathol. 2021;129(11):847–51. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet. 2005 Apr;365(9469):1500–5. Baeyens J-P, Serrien B, Goossens M, Clijsen R. Questioning the “SPIN and SNOUT” rule in clinical testing. Arch Physiother. 2019 912019 Mar;9(1):1–6. The uniform approach to breast fine-needle aspiration biopsy. Diagn Cytopathol. 1997 Jan;16(4):295–311. Wells CA, Ellis IO, Zakhour HD, Wilson AR. Guidelines for cytology procedures and reporting on fine needle aspirates of the breast. Cytopathology. 1994 Oct;5(5):316–34. Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. Quadas-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36. Robinson IA, Blackham RB. Is there a better way to assess performance in breast cytology? Cytopathology. 2001 Aug;12(4):227–34. Field AS, Schmitt F, Vielh P. IAC standardized reporting of breast fine-needle aspiration biopsy cytology. Acta Cytol. 2017 Feb;61(1):3–6. McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12:55–61. Chu H, Cole SR. Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol. 2006 Dec;59(12):1331–2. Takwoingi Y, Dendukuri N, Schiller I, Rücker G, Jones H, Partlett C, et al. Chapter 11: undertaking meta-analysis. In: Deeks J, Bossuyt P, Leeflang M, Takwoingi Y, editors. Cochrane handbook for systematic reviews of diagnostic test accuracy version 2. London: Cochrane. p Draft version for inclusion. Lin L, Chu H. altmeta: alternative meta-analysis methods; 2022. R Core Team. A language and environment or statistical computing; 2022. Freeman SC, Kerby CR, Patel A, Cooper NJ, Quinn T, Sutton AJ. Development of an interactive web-based tool to conduct and interrogate meta-analysis of diagnostic test accuracy studies: MetaDTA. BMC Med Res Methodol. 2019 Apr;19(1):1–11. Patel A, Cooper N, Freeman S, Sutton A. Graphical enhancements to summary receiver operating characteristic plots to facilitate the analysis and reporting of meta-analysis of diagnostic test accuracy data. Res Synth Methods. 2021 Jan;12(1):34–44. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. Debray T, de Jong V. metamisc: Meta-Analysis of Diagnosis and Prognosis Research Studies, R package version 0.2.5; 2021. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005 Sep;58(9):882–93. Rubinstein ML, Kraft CS, Parrott JS. Determining qualitative effect size ratings using a likelihood ratio scatter matrix in diagnostic test accuracy systematic reviews. Diagnosis. 2018 Dec;5(4):205–14. Hailey SR, Held L, Meyer S, Rueeger S, Rufibach K, Schwab S. biostatUZH: Misc Tools of the Department of Biostatistics, R package version 1.8.0/r103. EBPI, University of Zurich; 2020. Arul P, Masilamani S. Application of National Cancer Institute recommended terminology in breast cytology. J Cancer Res Ther. 2017;13(1):91–6. Ogbuanya AU-O, Anyanwu SN, Iyare EF, Nwigwe CG. The role of fine needle aspiration cytology in triple assessment of patients with malignant breast lumps. Niger J Surg Off Publ Niger Surg Res Soc. 2020;26(1):35–41. Ibikunle DE, Omotayo JA, Ariyibi OO. Fine needle aspiration cytology of breast lumps with histopathologic correlation in Owo, Ondo State, Nigeria: a five-year review. Ghana Med J. 2017;51(1):1–5. Madubogwu CI, Ukah CO, Anyanwu S, GU C, Onyiaorah IV, Anyiam D. Sub-classification of breast masses by fine needle aspiration cytology. Eur J breast Heal. 2017 Oct;13(4):194–9. Stephen M, Daye S-F, Raphael S. Palpable breast masses in a tertiary institution of South-South Nigeria; fine-needle aspiration cytology versus histopathology: a correlation of diagnostic accuracy. New Niger J Clin Res. 2018;7(12):43–7. Mohan BP, Krishnan SK, Prasad P, Jose L, Das NM, Feroze M. Correlation of fine needle aspiration cytology (FNAC) with histopathology in palpable breast lesions: a study of 200 cases from a tertiary care center in South India. J Med Sci Clin Res. 2018 Jul;6(7). Sackett DL, Straus S. On some clinically useful measures of the accuracy of diagnostic tests. ACP J Club. 1998;129(2):A17–9. Debray TPA, Damen JAAG, Snell KIE, Ensor J, Hooft L, Reitsma JB, et al. A guide to systematic review and meta-analysis of prediction model performance. BMJ. 2017 Jan;356:6460. Jamidi SK, Li JJX, Aphivatanasiri C, Chow MBCY, Chan RCK, Ng JKM, et al. Papillary lesions of the breast: a systematic evaluation of cytologic parameters. Cancer Cytopathol. 2021 Aug;129(8):649–61. Gümrükçü G, Doğan M, Gürsan N, Boylu B, Ekren E, Aker FV. How accurately FNAC reflects the breast papillary lesions? J Cytol. 2022;39(1):30–6. de Cursi JAT, Marques MEA, de Assis Cunha Castro CAC, Schmitt FC, Soares CT. Fine-Needle Aspiration Cytology (FNAC) is a reliable diagnostic tool for small breast lesions (≤1.0 cm): a 20-year retrospective study. Surg Exp Pathol. 2020;3(1). Oosthuizen M, Razack R, Edge J, Schubert PT. Classification of male breast lesions according to the IAC Yokohama System for reporting breast cytopathology. Acta Cytol. 2021;65(2):132–9. Hoda RS, Brachtel EF. International Academy of Cytology Yokohama System for reporting breast fine-needle aspiration biopsy cytopathology: a review of predictive values and risks of malignancy. Acta Cytol. 2019;63(Suppl 4):292–301. Field AS, Raymond WA, Rickard M, Arnold L, Brachtel EF, Chaiwun B, et al. The International Academy of Cytology Yokohama System for reporting breast fine-needle aspiration biopsy cytopathology. Acta Cytol. 2019;63(Suppl 4):257–73. Article / Publication Details

First-Page Preview

Abstract of Fine Needle Aspiration

Received: July 04, 2022
Accepted: September 14, 2022
Published online: November 22, 2022

Number of Print Pages: 16
Number of Figures: 5
Number of Tables: 4

ISSN: 0001-5547 (Print)
eISSN: 1938-2650 (Online)

For additional information: https://www.karger.com/ACY

留言 (0)

沒有登入
gif